oxazoles has been researched along with Coronary Thrombosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchanan, JO; Fleming, JS; Gamberdella, M; Meanwell, NA; Schumacher, WA; Seiler, SM; Zavoico, GB | 1 |
2 other study(ies) available for oxazoles and Coronary Thrombosis
| Article | Year |
|---|---|
A bumpy road to breakthroughs. The news: it's hard to beat today's cardiac treatments.
Topics: Animals; Atherosclerosis; Coronary Thrombosis; Diabetes Mellitus, Type 2; Ethics, Clinical; Glycine; Heart Failure; Humans; Indoleacetic Acids; Myocardial Infarction; Oxazoles; Prostheses and Implants; Stroke; Treatment Failure; Ultrasonography | 2006 |
2-[3-[2-(4,5-diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): 2). Oral activity and efficacy in animal models of arterial thrombosis.
Topics: Administration, Oral; Animals; Chlorocebus aethiops; Coronary Thrombosis; Disease Models, Animal; Dogs; Humans; Macaca fascicularis; Male; Oxazoles; Phenoxyacetates; Rabbits; Rats; Rats, Sprague-Dawley; Renal Artery Obstruction | 1994 |